Licensing began with medicine and law; now it extends to 20 percent of the U.S. workforce, including hair stylists and auctioneers. In a new book, the legal scholar Rebecca Allensworth calls licensing boards “a thicket of self-dealing and ineptitude” and says they keep bad workers in their jobs and good ones out — while failing to protect the public.
To most people, the rat is vile and villainous. But not to everyone! We hear from a scientist who befriended rats and another who worked with them in the lab — and from the animator who made one the hero of a Pixar blockbuster. (Part three of a three-part series, “Sympathy for the Rat.”)
Hear how Jan Pinkava created Ratatouille. To get Plus episodes, become a member at Apple Podcasts or at freakonomics.com/plus.
When the computer scientist Ben Zhao learned that artists were having their work stolen by A.I. models, he invented a tool to thwart the machines. He also knows how to foil an eavesdropping Alexa and how to guard your online footprint. The big news, he says, is that the A.I. bubble is bursting.
Even with a new rat czar, an arsenal of poisons, and a fleet of new garbage trucks, it won’t be easy — because, at root, the enemy is us. (Part two of a three-part series, “Sympathy for the Rat.”)
A brief meditation on loss, relativity, and the vagaries of show business.
The National Association of Realtors just lost a huge lawsuit. Their infamous commission model is under attack. And there are way too many of them. If they go the way of travel agents, will we miss them when they’re gone?
New York City’s mayor calls them “public enemy number one.” History books say they caused the Black Death — although recent scientific evidence disputes that claim. So is the rat a scapegoat? And what does our rat hatred say about us? (Part one of a three-part series.)
Running backs used to be the N.F.L.’s biggest stars, with paychecks to match. Now their salaries are near the bottom, and their careers are shorter than ever. We speak with an analytics guru, an agent, some former running backs (including LeSean McCoy), and the economist Roland Fryer (a former Pop Warner running back himself) to understand why.
Licensing began with medicine and law; now it extends to 20 percent of the U.S. workforce, including hair stylists and auctioneers. In a new book, the legal scholar Rebecca Allensworth calls licensing boards “a thicket of self-dealing and ineptitude” and says they keep bad workers in their jobs and good ones out — while failing to protect the public.
In 2023, the N.F.L. players’ union conducted a workplace survey that revealed clogged showers, rats in the locker room — and some insights for those of us who don’t play football. Today we’re updating that episode, with extra commentary from Omnipresent Football Guy (and former Philadelphia Eagle) Jason Kelce.
They used to be the N.F.L.’s biggest stars, with paychecks to match. Now their salaries are near the bottom, and their careers are shorter than ever. We speak with an analytics guru, an agent, some former running backs (including LeSean McCoy), and the economist Roland Fryer (a former Pop Warner running back himself) to understand why.
We conclude our look at penicillin allergy. And later: We tend to think of medicine as a science, but for most of human history it has been scientific-ish at best. We look at the grotesque mistakes produced by centuries of trial-and-error, and ask whether the new era of evidence-based medicine is the solution.
When the computer scientist Ben Zhao learned that artists were having their work stolen by A.I. models, he invented a tool to thwart the machines. He also knows how to foil an eavesdropping Alexa and how to guard your online footprint. The big news, he says, is that the A.I. bubble is bursting.
Like tens of millions of people, Stephen Dubner thought he had a penicillin allergy. Like the vast majority, he didn’t. This misdiagnosis costs billions of dollars and causes serious health problems, so why hasn’t it been fixed? And how about all the other things we think we’re allergic to?
Stephen Dubner, live on stage, mixes it up with outbound mayor London Breed, and asks economists whether A.I. can be “human-centered” and if Tang is a gateway drug.
Medical anthropologist Theresa MacPhail explains the rapid rise in allergies over the last few decades.
To get Plus episodes, become a member at Apple Podcasts or at freakonomics.com/plus.
Their trade organization just lost a huge lawsuit. Their infamous commission model is under attack. And there are way too many of them. If they go the way of travel agents, will we miss them when they’re gone?
We conclude our series on academic fraud. And later: We all like to throw around terms that describe human behavior — “bystander apathy” and “steep learning curve” and “hard-wired.” Most of the time, they don’t actually mean what we think they mean. But don’t worry — the experts are getting it wrong, too.
Like tens of millions of people, Stephen Dubner thought he had a penicillin allergy. Like the vast majority, he didn’t. This misdiagnosis costs billions of dollars and causes serious health problems, so why hasn’t it been fixed? And how about all the other things we think we’re allergic to?
Can academic fraud be stopped? Probably not — the incentives are too strong. But a few reformers are trying. (Part 2 of a series)
Some of the biggest names in behavioral science stand accused of faking their results. Last year, an astonishing 10,000 research papers were retracted. In a series originally published in early 2024, we talk to whistleblowers, reformers, and a co-author who got caught up in the chaos. (Part 1 of a series)
Probably not — the incentives are too strong. But a few reformers are trying. We check in on their progress, in an update to an episode originally published last year. (Part 2 of 2)
Adam Moss was the best magazine editor of his generation. When he retired, he took up painting. But he wasn’t very good, and that made him sad. So he wrote a book about how creative people work— and, in the process, he made himself happy again.
Some of the biggest names in behavioral science stand accused of faking their results. Last year, an astonishing 10,000 research papers were retracted. In a series originally published in early 2024, we talk to whistleblowers, reformers, and a co-author who got caught up in the chaos. (Part 1 of 2)
In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. healthcare system — and what a second Trump term means for healthcare policy.
Adam Moss was the best magazine editor of his generation. When he retired, he took up painting. But he wasn’t very good, and that made him sad. So he wrote a book about how creative people work— and, in the process, he made himself happy again.
Adam Moss was the best magazine editor of his generation. When he retired, he took up painting. But he wasn’t very good, and that made him sad. So he wrote a book about how creative people work— and, in the process, he made himself happy again.
Retail expert Mark Cohen explains the social, economic, and cultural forces behind the decline of department stores like Sears and Macy’s. To get Plus episodes, sign up for SiriusXM Podcasts+ on Apple Podcasts.
John J. Sullivan, a former State Department official and U.S. ambassador, says: “Our politicians aren’t leading — Republicans or Democrats.” He gives a firsthand account of a fateful Biden-Putin encounter, talks about his new book Midnight in Moscow, and predicts what a second Trump term means for Russia, Ukraine, China — and the U.S.
You want to listen to Freakonomics Radio? That’s great! Most people use a podcast app on their smartphone. It’s free (with the purchase of a phone, of course). Looking for more guidance? We’ve got you covered.
Stay up-to-date on all our shows. We promise no spam.
